223 related articles for article (PubMed ID: 25351424)
1. Familial tumoral calcinosis.
Alkhatib A; Burton LE; Carachi R
Scott Med J; 2014 Nov; 59(4):e17-20. PubMed ID: 25351424
[TBL] [Abstract][Full Text] [Related]
2. Response to acetazolamide in a patient with tumoral calcinosis.
Landini-Enríquez V; Escamilla MA; Soto-Vega E; Chamizo-Aguilar K
Nefrologia; 2015; 35(5):503-5. PubMed ID: 26388352
[No Abstract] [Full Text] [Related]
3. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
Finer G; Price HE; Shore RM; White KE; Langman CB
Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
[TBL] [Abstract][Full Text] [Related]
5. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
Ichikawa S; Lyles KW; Econs MJ
J Clin Endocrinol Metab; 2005 Apr; 90(4):2420-3. PubMed ID: 15687324
[TBL] [Abstract][Full Text] [Related]
6. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in
Döneray H; Özden A; Gürbüz K
J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):239-243. PubMed ID: 33685073
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.
Anilkumar A; Högler W; Bursell J; Nadar R; Ryan F; Randell T; Shaw NJ; Uday S
Bone; 2024 May; 182():117049. PubMed ID: 38364881
[TBL] [Abstract][Full Text] [Related]
8. Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
Otukesh H; Hoseini R; Chalian H; Chalian M; Safarzadeh AE; Shakiba M; Poorian A
Pediatr Nephrol; 2007 Aug; 22(8):1235-7. PubMed ID: 17437133
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in
Kışla Ekinci RM; Gürbüz F; Balcı S; Bişgin A; Taştan M; Yüksel B; Yılmaz M
J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):94-99. PubMed ID: 30015621
[TBL] [Abstract][Full Text] [Related]
10. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
[TBL] [Abstract][Full Text] [Related]
11. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
[TBL] [Abstract][Full Text] [Related]
12. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
[TBL] [Abstract][Full Text] [Related]
13. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
[TBL] [Abstract][Full Text] [Related]
14. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.
Goldenstein PT; Neves PD; Balbo BE; Elias RM; Pereira AC; Onuchic LF; Jüppner H; Jorgetti V; Abensur H; Moysés RM
Am J Kidney Dis; 2018 Sep; 72(3):457-461. PubMed ID: 29548779
[TBL] [Abstract][Full Text] [Related]
15. Familial tumoral calcinosis: a forty-year follow-up on one family.
Carmichael KD; Bynum JA; Evans EB
J Bone Joint Surg Am; 2009 Mar; 91(3):664-71. PubMed ID: 19255228
[TBL] [Abstract][Full Text] [Related]
16. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
[TBL] [Abstract][Full Text] [Related]
17. Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity.
Lyles KW; Burkes EJ; Ellis GJ; Lucas KJ; Dolan EA; Drezner MK
J Clin Endocrinol Metab; 1985 Jun; 60(6):1093-6. PubMed ID: 3998061
[TBL] [Abstract][Full Text] [Related]
18. [Familial tumoral calcinosis in three patients in the same family].
Yurdoğlu C; Ozbaydar MU; Adaş M; Ozger H
Acta Orthop Traumatol Turc; 2007; 41(3):244-8. PubMed ID: 17876123
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.
Larsson T; Davis SI; Garringer HJ; Mooney SD; Draman MS; Cullen MJ; White KE
Endocrinology; 2005 Sep; 146(9):3883-91. PubMed ID: 15961556
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.
Araya K; Fukumoto S; Backenroth R; Takeuchi Y; Nakayama K; Ito N; Yoshii N; Yamazaki Y; Yamashita T; Silver J; Igarashi T; Fujita T
J Clin Endocrinol Metab; 2005 Oct; 90(10):5523-7. PubMed ID: 16030159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]